Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Georgina Okecha"'
Autor:
Emma L. Davies, Mahlaqua Noor, Eleanor Y. Lim, Charlotte J. Houldcroft, Georgina Okecha, Claire Atkinson, Matthew B. Reeves, Sarah E. Jackson, Mark R. Wills
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Human cytomegalovirus (HCMV) infection and periodic reactivation is, generally, well controlled by adaptative immune responses in the healthy. In older people, overt HCMV disease is rarely seen despite the association of HCMV with increased risk of m
Externí odkaz:
https://doaj.org/article/1bf0e06452cf4928b7da81b151877001
Autor:
Sarah E. Jackson, George X. Sedikides, Veronika Romashova, Georgina Okecha, Ester B. M. Remmerswaal, Frederike J. Bemelman, John H. Sinclair, Mark R. Wills
Publikováno v:
Pathogens, Vol 11, Iss 12, p 1530 (2022)
HCMV-specific CD8+ T-cells are potent anti-viral effector cells in HCMV infected individuals, but evidence from other viral infections suggests that CD8+ T-cells can also produce the immunomodulatory cytokine IL-10. In this work we show that there ar
Externí odkaz:
https://doaj.org/article/97e1dc3c06b840ab84bb43b3089f9a30
Autor:
Sarah E. Jackson, Kevin C. Chen, Ian J. Groves, George X. Sedikides, Amar Gandhi, Charlotte J. Houldcroft, Emma L. Poole, Inmaculada Montanuy, Gavin M. Mason, Georgina Okecha, Matthew B. Reeves, John H. Sinclair, Mark R. Wills
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Human cytomegalovirus (HCMV) infection is not cleared by the initial immune response but persists for the lifetime of the host, in part due to its ability to establish a latent infection in cells of the myeloid lineage. HCMV has been shown to manipul
Externí odkaz:
https://doaj.org/article/e97d64960ba34f25aabbe32eb204d4f4
Autor:
Charlotte J. Houldcroft, Sarah E. Jackson, Eleanor Y. Lim, George X. Sedikides, Emma L. Davies, Claire Atkinson, Megan McIntosh, Ester B. M. Remmerswaal, Georgina Okecha, Frederike J. Bemelman, Richard J. Stanton, Matthew Reeves, Mark R. Wills
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
HCMV infection, reinfection or reactivation occurs in 60% of untreated solid organ transplant (SOT) recipients. Current clinical approaches to HCMV management include pre-emptive and prophylactic antiviral treatment strategies. The introduction of im
Externí odkaz:
https://doaj.org/article/c957e715247a4216b671c302c8ecb427
Autor:
Sarah E. Jackson, George X. Sedikides, Georgina Okecha, Emma L. Poole, John H. Sinclair, Mark R. Wills
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Human cytomegalovirus (HCMV) primary infection and periodic reactivation of latent virus is generally well controlled by T-cell responses in healthy people. In older donors, overt HCMV disease is not generally seen despite the association of HCMV inf
Externí odkaz:
https://doaj.org/article/4a56bd72c8d84e68b03b45a88dcf500c
Autor:
Gavin M Mason, Sarah Jackson, Georgina Okecha, Emma Poole, J G Patrick Sissons, John Sinclair, Mark R Wills
Publikováno v:
PLoS Pathogens, Vol 9, Iss 10, p e1003635 (2013)
Human cytomegalovirus (HCMV) is a widely prevalent human herpesvirus, which, after primary infection, persists in the host for life. In healthy individuals, the virus is well controlled by the HCMV-specific T cell response. A key feature of this pers
Externí odkaz:
https://doaj.org/article/194ca46ac7724fb29a38e47d5120201f
Autor:
Emma L. Davies, Mahlaqua Noor, Eleanor Y. Lim, Charlotte J. Houldcroft, Georgina Okecha, Claire Atkinson, Matthew B. Reeves, Sarah E. Jackson, Mark R. Wills
Peer reviewed: True
Human cytomegalovirus (HCMV) infection and periodic reactivation is, generally, well controlled by adaptative immune responses in the healthy. In older people, overt HCMV disease is rarely seen despite the association of HCMV
Human cytomegalovirus (HCMV) infection and periodic reactivation is, generally, well controlled by adaptative immune responses in the healthy. In older people, overt HCMV disease is rarely seen despite the association of HCMV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b66ed4fe3cb53310f3cfd53cbdf89e3a
Autor:
Georgina Okecha, George X. Sedikides, Mark R. Wills, Amar Gandhi, Gavin M. Mason, Kevin C. Chen, Sarah E. Jackson, Inmaculada Montanuy, John Sinclair, Ian J. Groves, Matthew B. Reeves, Charlotte J. Houldcroft, Emma Poole
Publikováno v:
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
instname
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Human cytomegalovirus (HCMV) infection is not cleared by the initial immune response but persists for the lifetime of the host, in part due to its ability to establish a latent infection in cells of the myeloid lineage. HCMV has been shown to manipul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d5423e43516900a803d0f76d06003d
http://hdl.handle.net/10641/2825
http://hdl.handle.net/10641/2825
Publikováno v:
Medical Microbiology and Immunology
Understanding how the T cell memory response directed towards human cytomegalovirus (HCMV) develops and changes over time while the virus persists is important. Whilst HCMV primary infection and periodic reactivation is well controlled by T cell resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b93453081428c5d300fd5a9dd98a1535
https://pubmed.ncbi.nlm.nih.gov/30895366
https://pubmed.ncbi.nlm.nih.gov/30895366
Human cytomegalovirus (HCMV) infection and periodic reactivation are generally well controlled by the HCMV-specific T cell response in healthy people. While the CD8 + T cell response to HCMV has been extensively studied, the HCMV-specific CD4 + T cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09639ad74a28f82505d9e647fc7b3423
https://europepmc.org/articles/PMC5331818/
https://europepmc.org/articles/PMC5331818/